Low Peripheral Blood Counts and Elevated Proinflammatory Cytokines Signal a Poor CD19 Chimeric Antigen Receptor T-cell Response in Acute Lymphoblastic Leukemia
Katelyn Burleigh(Seattle Children's Hospital), Heather Gustafson(Seattle Children's Hospital), Bobbie‐Jo Webb‐Robertson(Pacific Northwest National Laboratory), Alexandre V. Hirayama(University of Washington), Jenny L. Smith(Seattle Children's Hospital), Camille Keenan(University of Washington), Corinne Summers(Seattle Children's Hospital), Rebecca Gardner(Seattle Children's Hospital), Cameron J. Turtle(The University of Sydney), Kelly G. Stratton(Pacific Northwest National Laboratory), Colleen Annesley(Unknown), Michael C. Jensen(Seattle Children's Hospital)
Cited by 3
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k